| 상품명칭 |
Diprenorphine |
| 영문 이름 |
Diprenorphine;Diprenorphine [INN:BAN]; Diprenorphine; Diprenorfina; Diprenorfina [INN-Spanish]; Diprenorphinum; Diprenorphinum [INN-Latin]; M50-50; M50-50 Injection; 21-Cyclopropyl-6,7,8,14-tetrahydro-7alpha-(1-hydroxy-1-methylethyl)-6,14-endo-ethanooripavine; 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)-; DEA No. 9058; (14beta)-17-(cyclopropylmethyl)-18-(2-hydroxypropan-2-yl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol; (5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-(2-hydroxypropan-2-yl)-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol |
| 분자식 |
C26H35NO4 |
| 분자량 |
425.5604 |
| InChI |
InChI=1/C26H35NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-7,15,18-19,22,28-29H,4-5,8-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1 |
| cas번호 |
14357-78-9 |
| EC번호 |
238-325-7 |
| 분자 구조 |
|
| 밀도 |
1.33g/cm3 |
| 굴절 지수 |
1.656 |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
